Genentech CFO

Genentech CFO Lou Lavigne will retire in March 2005 after serving as a Genentech finance exec for over 22 years. He first served as controller and was promoted to CFO in 1988. In his retirement, Lavigne intends to serve on the boards of other companies. Senior VP-Product Operations David Ebersman will replace Lavigne as CFO. Pat Yang, PhD, who serves as VP-South San Francisco manufacturing & engineering, will be promoted to senior VP-product operations. Yang joined the company from Merck in late 2003 (1"The Pink Sheet" Jan. 19, 2004, In Brief)...